Claris Lifesciences Ltd

Claris Lifesciences Ltd

₹ 397 -0.06%
14 Mar 2018
About

Claris Lifesciences Limited is engaged in manufacturing of drugs and pharmaceutical products.

  • Market Cap 2,164 Cr.
  • Current Price 397
  • High / Low /
  • Stock P/E
  • Book Value -2.14
  • Dividend Yield 0.00 %
  • ROCE -2.85 %
  • ROE %
  • Face Value 10.0

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017
162 134 141 145 24 9 1 1 3 1 2 3 0
146 147 143 157 62 29 12 24 21 11 15 13 375
Operating Profit 15 -13 -2 -12 -37 -20 -12 -23 -18 -10 -14 -10 -374
OPM % 9% -10% -2% -8% -153% -226% -1,518% -3,134% -587% -696% -912% -371% -267,457%
26 19 10 14 18 18 18 25 22 2 14 1,717 57
Interest 4 1 0 1 1 2 1 1 1 1 1 1 1
Depreciation 3 1 2 0 1 1 1 0 1 1 1 1 1
Profit before tax 33 4 5 2 -21 -5 4 1 2 -10 -2 1,705 -319
Tax % -152% 9% 15% 507% 19% 108% 3% -505% -262% 42% 102% 1% -0%
84 4 4 -8 -17 0 4 5 8 -6 0 1,694 -320
EPS in Rs 15.34 0.70 0.80 -1.48 -3.12 0.08 0.73 0.92 1.52 -1.05 0.01 310.38 -58.67
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
624.73 625.59 651.39 718.02 638.18 722.28 122.05 0.00 0.00 0.00 0.00 0.00
439.65 450.84 462.12 486.72 503.58 659.04 161.17 10.33 25.04 12.06 1.46 0.31
Operating Profit 185.08 174.75 189.27 231.30 134.60 63.24 -39.12 -10.33 -25.04 -12.06 -1.46 -0.31
OPM % 29.63% 27.93% 29.06% 32.21% 21.09% 8.76% -32.05%
14.47 15.98 15.28 11.68 78.67 104.59 24.03 21.46 36.19 7.63 0.46 0.04
Interest 52.83 46.62 55.30 64.91 52.10 31.04 3.91 0.00 0.00 0.00 0.00 0.00
Depreciation 44.46 46.38 54.34 71.79 57.96 29.58 3.56 0.14 0.10 0.00 0.00 0.00
Profit before tax 102.26 97.73 94.91 106.28 103.21 107.21 -22.56 10.99 11.05 -4.43 -1.00 -0.27
Tax % 12.91% 19.14% 26.51% 29.99% 21.31% -29.35% 10.20% -5.10% 15.48% -59.82% -401.00% 0.00%
89.06 79.02 69.75 74.42 81.22 138.69 -20.26 11.56 9.34 -7.08 -5.01 -0.27
EPS in Rs 12.38 10.93 11.66 12.73 25.42 -3.71 2.12 1.71 -1.30 -0.92 -0.05
Dividend Payout % 11.49% 16.15% 18.30% 17.15% 70.72% 0.00% -53.87% 94.41% 116.85% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 95%
Stock Price CAGR
10 Years: 10%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity Capital 34.12 63.82 63.82 63.82 63.82 54.57 54.57 54.57 54.57 54.57 54.57 54.57
Reserves 444.36 758.25 812.81 872.39 886.31 803.00 687.69 685.71 -53.86 -60.94 -65.96 -66.23
314.01 360.63 408.64 542.09 267.78 38.88 13.77 21.55 0.00 0.00 20.97 21.01
364.23 337.90 284.56 326.00 515.49 372.34 246.01 176.17 23.31 28.10 0.40 0.43
Total Liabilities 1,156.72 1,520.60 1,569.83 1,804.30 1,733.40 1,268.79 1,002.04 938.00 24.02 21.73 9.98 9.78
489.76 528.65 661.54 804.74 505.13 38.33 33.50 50.01 0.00 0.00 0.00 0.00
CWIP 123.23 185.71 41.91 174.27 173.29 1.77 6.06 2.40 0.00 0.00 0.00 0.00
Investments 17.06 17.06 17.06 16.66 627.43 350.88 222.94 230.30 0.00 0.00 0.00 0.00
526.67 789.18 849.32 808.63 427.55 877.81 739.54 655.29 24.02 21.73 9.98 9.78
Total Assets 1,156.72 1,520.60 1,569.83 1,804.30 1,733.40 1,268.79 1,002.04 938.00 24.02 21.73 9.98 9.78

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
187.37 110.24 62.32 247.75 121.96 48.58 -557.42 -42.14 -2.03 -0.14 6.17 -0.11
-103.74 -143.99 -204.04 -340.98 217.22 233.97 610.45 28.02 -6.93 0.35 0.41 0.05
-56.76 280.86 -24.07 51.12 -342.78 -329.78 -28.93 -8.91 -13.14 0.00 -6.67 -0.01
Net Cash Flow 26.87 247.11 -165.79 -42.11 -3.60 -47.23 24.10 -23.03 -22.10 0.21 -0.09 -0.06

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 141.02 147.81 136.64 126.04 88.53 76.74 233.95
Inventory Days 204.86 215.40 219.01 259.85 58.89 0.00 0.00
Days Payable 186.82 193.14 105.22 151.80 154.80
Cash Conversion Cycle 159.05 170.08 250.44 234.09 -7.38 76.74 233.95
Working Capital Days 99.77 124.20 161.15 127.50 -118.56 231.24 1,243.69
ROCE % 20.95% 14.66% 12.22% 12.42% 10.02% 10.89% 2.49% 1.45% 2.41% -62.31% -2.85%

Shareholding Pattern

Numbers in percentages

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017
60.99% 52.56% 50.13% 50.13% 50.13% 50.13% 50.13%
20.29% 25.43% 25.86% 26.48% 26.22% 25.62% 26.02%
1.35% 1.35% 1.49% 1.86% 1.86% 1.94% 1.94%
17.36% 20.66% 22.52% 21.53% 21.79% 22.31% 21.91%
No. of Shareholders 20,98320,54920,11719,65918,19817,90217,032

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents